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Background: Sleep apnea leads to cognitive impairment in older patients, but its
association with neurodegeneration remains controversial, and most studies do not
distinguish between the more common obstructive form (OSAS) and the rarer central
form (CSAS).
Objective: The purpose of this study was to assess the prevalence of the different
forms of sleep apnea in a cohort of cognitively impaired elderly patients (>70 years)
and to investigate their associations with cognitive deficit, weighted against known risk
factors for neurodegeneration.
Methods: Overnight polygraphy was performed for 76 consecutive patients admitted
to our geriatric unit. Their cognitive function was assessed using the Mini Mental-State
Exam (MMSE), Mattis Dementia Rating Scale (MDRS) and Stroop test. Multivariable
analyses were performed to determine associations between cognitive function
and independent variables describing demographics, sleep apnea measures, and
cardiovascular risk factors.
Results: The cohort comprised 58 women and 18 men aged a mean of 84 years (range,
73–96). Sleep apnea syndrome (SAS) was diagnosed in 48 patients (63%), of which 31
(41%) with OSAS and 17 (22%) with CSAS. Multivariable regression analysis revealed
that MDRS was lower in patients with OSAS (β = −10.03, p = 0.018), that Stroop Colors
and Words delays increased with AHI (β = 0.17, p = 0.030 and β = 0.31, p = 0.047)
and that that Stroop Interference delay was higher in patients with CSAS (β = 24.45,
p = 0.002).
Conclusion: Sleep apnea is thus highly prevalent in elderly patients with cognitive
impairment. OSAS was associated with lower general cognitive function, while CSAS
was only associated with increased Stroop Interference delays. Elderly patients with
cognitive deficit could benefit from sleep apnea screening and treatment.
Keywords: sleep apnea, cognitive deficit, elderly population, OSAS, CSAS
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INTRODUCTION
Sleep apnea syndrome (SAS) is a disorder characterized by
repeated pauses in breathing during sleep (Young et al.,
1993). It is often underdiagnosed (Peppard et al., 2013),
though its prevalence is increasing and was recently shown
to be up to 40% in the general population (Heinzer et al.,
2015), and likely higher in the elderly population (Al Lawati
et al., 2009; Heinzer et al., 2015). SAS interrupts sleep
and causes intermittent hypoxia (Rosenzweig et al., 2015)
which could contribute to a range of pathophysiological
consequences, including cognitive impairment (Wallace and
Bucks, 2013; Arli et al., 2015), particularly in older patients
(Yaffe et al., 2011; Osorio et al., 2015; Tsapanou et al.,
2018). In fact, SAS is more prevalent in patients suffering
from neurodegenerative diseases (Moran et al., 2005; Emamian
et al., 2016) and is suspected to increase risks of developing
Alzheimer’s disease (Aoki et al., 2014; Osorio et al., 2015;
Liguori and Placidi, 2018).
The association between SAS and neurodegenerative diseases
remains controversial (Somers et al., 2008; Rosenzweig et al.,
2015) and the pathophysiological consequences of SAS are still
unclear (Yaffe et al., 2011; Zimmerman and Aloia, 2012; Martin
et al., 2015; Bubu et al., 2019). This is further complicated
by the fact that most studies do not distinguish between
the more common obstructive form (OSAS), characterized
by recurrent collapse of the upper respiratory tract, and
the rarer central form (CSAS), characterized by repetitive
pauses in breathing without respiratory effort. Moreover, the
causes of cognitive impairments are difficult to establish in
patients over 70 years old, who often exhibit multiple co-
morbidities.
Validated modifiable risk factors can be used to mitigate the
progression of age-related cognitive decline. For instance, OSAS
is associated with Alzheimer’s disease biomarker accumulation
(Bubu et al., 2019) and can be treated with continuous positive
airway pressure (CPAP) (Marshall et al., 2006; Cooke et al.,
2009; Kylstra et al., 2013; Richards et al., 2019), which improves
cognitive function in patients suffering from Alzheimer’s
disease, although its effect on pathological progression remains
unknown (Ancoli-Israel et al., 2008; Troussiere et al., 2014;
Dostalova et al., 2019). The purpose of this exploratory
study was therefore to (a) assess the prevalence of each
form of SAS in a cohort of elderly patients (>70 years
old) admitted to our geriatric unit for non-acute reasons,
and (b) investigate the independent relation between sleep
apnea and cognitive performance, measured using validated
tests, including the Mini Mental-State Exam (MMSE), the
Mattis Dementia rating Scale (MDRS) and the Stroop test,
and competing against known risk factors for cognitive
impairment. The hypothesis was that (i) the prevalence of
SAS in elderly patients consulting for cognitive deficit would
be greater than that reported for the general population
and (ii) elderly patients with SAS would have significantly
worse MMSE, MDRS and Stroop test scores, independently of
confounding factors.
MATERIALS AND METHODS
We enrolled 115 consecutive patients admitted to our geriatric
unit for non-acute reasons (non-emergency, no surgery, no
mandatory overnight stay) between October 2015 and March
2018. The inclusion criterion was patients aged over 70 years.
The exclusion criteria were (i) refusal to undergo sleep apnea
diagnosis with overnight polygraph recording (26 patients), or
(ii) refusal or inability to complete neurocognitive assessment
using structural cerebral magnetic resonance imaging (MRI)
(12 patients). In addition, 1 patient died before completing the
cognitive assessment, which left a study cohort of 76 patients
(Figure 1), who underwent overnight ambulatory polygraphy
(Weinmann SOMNOlab 2, Hamburg, Germany) to measure
their Apnea-Hypopnea Index (AHI), total number of events
per night, mean arterial blood oxygen saturation (SaO2) and
sleep time at SaO2 below 90% (Kuwabara et al., 2018). Apnea
severity was noted based on the AHI, as mild (AHI 5–15),
moderate (AHI 16–30), or severe (AHI > 30). Apneas were
defined as cessation of airflow for at least 10 s and hypopneas
were defined as a reduction of airflow to ≤50% of baseline
for at least 10 s (Somers et al., 2008). The final diagnosis
of sleep apnea, obstructive (OSAS) or central (CSAS) was
determined by a pulmonologist (YD) based on the relative
number of obstructive or central events per night, based on the
definition by Somers et al. (2008): obstructive sleep apnea is
characterized by ongoing ventilatory effort while central sleep
apnea is characterized by withdrawal of central respiratory
drive. OSAS and CSAS were defined when a patient had 5
or more episodes of obstructive or central apneas per hour of
sleep, respectively.
The patient’s overall cognitive function was assessed by
clinical psychologists (IG and ASM) using the following validated
scores: (a) Mini-Mental State Examination (MMSE) (Kalafat
Michel et al., 2003), which ranges from 0 to 30 points.
Patients scoring ≤23 considered cognitively impaired. (b) MDRS,
which comprises five subscales, spanning the areas of attention,
initiation-perseveration, construction, conceptualization and
FIGURE 1 | Flowchart of patient inclusions and exclusions.
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memory (Hersch, 1979; Gardner et al., 1981). (Heinzer et al.,
2015) Stroop Colors and Words test was used to assess attention
and executive functioning (Comalli et al., 1962), which are
known to be affected by sleep apnea (Olaithe and Bucks, 2013;
Martin et al., 2015; Rosenzweig et al., 2015). The Colors test
asks patients to recognize the color of dots that appear for
a short time, while the Words test asks them to read words
(names of colors) that appear for a short time. The Interference
test requires the patients to read the words (names of colors)
TABLE 1 | Patient demographics.
Cohort (n = 76)
Median [IQR] (Range)
Age (years) 84 [80–88] (73–96)
BMI (kg/m2) 24 [21–27] (16–40)
Depression (MADRS∗/60) 6 [3–11] (0–31)






Vitamin D deficiency 40 (53%)
Anemia 51 (67%)
Hypertension (awake) 23 (32%)
Hypertension (asleep) 41 (59%)
Diagnosis
Mild cognitive impairment 33 (43%)
Vascular dementia 9 (12%)
Alzheimer’s disease 7 (9%)
Dementia with Lewy bodies 1 (1%)
Mixed dementia 26 (34%)
∗Montgomery-Asberg Depression Rating Scale. IQR, Interquartile range.
TABLE 2 | Sleep Apnea Syndrome.
Cohort (n = 76)
Median [IQR] (Range)
Blood oxygen saturation (SpO2,%) 95 [93–96] (87–98)
Sleep time with hypoxia∗(%) 2 [1–7] (0–54)
Number of events per night 56 [22–113] (2–548)
Apnea-hypopnea index (AHI) 16 [5–35] (1–73)
n (%)
SAS severity (AHI)
None (<5) 19 (25%)
Mild (5–15) 18 (24%)
Moderate (15–30) 7 (9%)
Severe (>30) 32 (42%)
Sleep Apnea Syndrome (SAS) 48 (63%)
Obstructive 31 (41%)
Central 17 (22%)
∗Hypoxia defined as a reduction of SpO2 by 10%. IQR, Interquartile range.
written in different (wrong) colors and repress the wrong answer
(Stroop interference effect). For all tests, the delay before the
answer, and the number of uncorrected mistakes, are reported.
(Al Lawati et al., 2009) Montgomery-Asberg Depression rating
scale [MADRS (Montgomery and Asberg, 1979)], on 60 points,
and Goldberg anxiety scale (Huber et al., 1999) on nine points, to
rule out effects of depression or anxiety on cognitive test results.
Final etiological diagnosis of cognitive impairment was
based on the neurocognitive assessments, as well as MRI
(Siemens Avanto 27780, Munich, Germany) results and history
of geriatric consultations. Mild cognitive impairment was
diagnosed following the criteria of Petersen et al. (2001), while
Alzheimer’s disease (AD) and AD-like diseases were diagnosed
according to the Diagnostic and Statistical Manual of Mental
Disorders, 4th Edition (DSM-IV) and the recommendations
of the National Institute on Aging – Alzheimer’s Association
workgroups (McKhann et al., 2011).
Vascular risk factors for the development of AD (Yaffe
et al., 2011) were diagnosed based on a comprehensive
assessment performed in our geriatric unit. Blood samples
were obtained after a minimum of 10 h of fasting. The
diagnosis of vitamin D [25(OH)D3] deficiency was given if blood
measurements were below 30 ng/mL, diabetes was diagnosed
with blood glucose levels above 7 mmol/L and anemia with
hemoglobin levels below 12 (women) or 13 (men) g/dL.
Likewise, the reference range was 4.1–6.5 mmol/L for total
cholesterol and 0.6–1.8 mmol/L for triglycerides. Inflammation
was diagnosed if the blood levels of C-reactive protein (CRP)
was higher than 10 mg/L (McMorris et al., 2017) as per the
recommendations of the World Health Organization (World
Health Organization [WHO], 2014), and leucocyte concentration
was higher than 100000/mm3. The blood pressure of patients
was measured during waking hours, and after polygraphy,
during night-time hours.
Written informed consent was obtained from all patients
for their participation and confirmed by their next-of-kin if
necessary. The study protocol was approved by an independent
Ethical Review Board (CPP Amiens: 2015/6) and the national
Data Protection Authority (CNIL:150075B-31). The study
was registered in clinicaltrials.gov (NCT02578303). All
TABLE 3 | Cognitive Tests.
Cohort (n = 76)
Median [IQR] (Range)
Mini-mental state exam (MMSE/30) 23 [19–26] (7–30)
Mattis dementia rating scale (MDRS/144) 121 [109–132] (60–143)
Stroop color and word test
Colors (delay, s) 19 [15–29] (6–70)
Colors (non-corrected mistakes) 0 [0–0] (0–6)
Words (delay, s) 34 [25–50] (14–147)
Words (non-corrected mistakes) 0 [0–1] (0–9)
Interference (delay, s) 53 [38–76] (15–116)
Interference (non-corrected mistakes) 4 [1–13] (0–24)
IQR, Interquartile range.
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procedures were performed in accordance with the 1964
Helsinki declaration.
Statistical Analysis
Descriptive statistics were used to summarize the data. Shapiro–
Wilk tests were used to assess the normality of distributions.
Due to skewed distribution of continuous variables, the data
was presented as median [IQR]. Univariable regressions were
performed to determine associations between five outcomes
(MMSE, MDRS and Stroop Colors, Words, and Interference
tests) and seventeen independent variables (age, BMI, sex,
diagnosis of SAS, OSAS, or CSAS, AHI, sleep apnea severity,
blood oxygen saturation, sleep time with hypoxia, number of
events per night, diabetes, inflammation, hypercholesterolemia,
hypertriglyceridemia, vitamin D deficiency, and anemia).
Variables that do not measure sleep apnea were included
because they represent cardiovascular risk factors known to
affect sleep apnea or cognition in elderly patients (Fusetti et al.,
2012). Multivariable regressions were then performed after
backward selection (criterion p < 0.15). Hypercholesterolemia
was excluded from the multivariable models due to a low
incidence (n < 10) in our cohort. Sample size of 47 patients was
calculated to be sufficient to show even the moderate negative
correlation between the MDRS and the AHI with 80% power and
5% significance. Therefore, our sample size of 76 was deemed
sufficient for analysis, considering a probably high failure rate in
the neurocognitive tests due to the age of the patients. Statistical
analyses were performed using R version 3.3.2 (R Foundation for
Statistical Computing, Vienna, Austria). P-values < 0.05 were
considered statistically significant.
RESULTS
The final cohort comprised 58 women (76%) and 18 men
(24%), aged 84 [IQR, 80–88] years (range, 73–96), with BMI 24
[IQR, 21–27] kg/m2 (range, 15.6–40) (Table 1). Overall, they
were not depressed (MADRS:6, IQR, 3–11; range, 0–31) nor
anxious (Goldberg:3, IQR, 1–5; range, 0–9). A number of patients
presented comorbidities, including heart failure (11.8%), aortic
stenosis (3.9%), mitral stenosis (1.3%), carotid stenosis (3.9%),
cerebral hematoma (3.9%), transient ischemic accident (3.9%),
and cancer (25%). The prevalence of arterial hypertension was
32% while awake but rose to 59% while asleep. Thirty-three
patients (43%) had mild cognitive impairment, 9 (12%) had
vascular dementia, 7 (9%) had Alzheimer’s disease, 1 (1%) had
Lewy-body dementia, and 26 (34%) had mixed dementia.
The median AHI was 16.4 (IQR, 5.4–35.3; range, 0.5–73), and
indicated severe sleep apnea in 32 patients (42%) (Table 2). SAS
was diagnosed in 48 patients (63%), of which 31 (41%) with OSAS
and 17 (22%) with CSAS.
The median MMSE score was 22.5 (IQR, 19–26; range, 7–
30), with 41 (54%) patients scoring ≤23 (Table 3). Univariable
regression revealed the MMSE score to be associated with sex and
diabetes (Table 4). There was no significant difference in MMSE
between patients with moderate to severe SAS and patients with
TABLE 4 | Uni- and Multi-variable regression to identify factors associated with the Mini Mental State Exam (MMSE).
Univariable Multivariable (n = 71) Backward selection
Regression coefficient 95% C.I. (range) p-Value Regression coefficient 95% C.I. (range) p-Value
Age −0.19 (−0.39 to 0.02) 0.072 −0.25 (−0.45 to −0.05) 0.014
BMI (kg/m2) 0.14 (−0.09 to 0.37) 0.226
Female Gender −2.72 (−5.37 to 0.08) 0.044
SAS 0.07 (−2.22 to 2.35) 0.955
OSAS −0.29 (−2.58 to 2.00) 0.801
CSAS 0.92 (−1.86 to 3.70) 0.510
Apnea-hypopnea index (AHI) 0.01 (−0.05 to 0.07) 0.723 0.04 (−0.01–0.10) 0.142
Sleep apnea severity
None REF
Mild 1.11 (−2.08 to 4.31) 0.489
Moderate −3.44 (−7.90 to 1.01) 0.128
Severe 0.35 (−2.46 to 3.15) 0.806
Blood oxygen saturation (SpO2,%) −0.07 (−0.60 to 0.45) 0.787
Sleep time with hypoxia∗ (%) 0.01 (−0.07 to 0.10) 0.738
Number of events per night 0.00 (−0.01 to 0.01) 0.438
Diabetes −4.02 (−7.30 to −0.73) 0.017 −4.91 (−8.10 to −1.72) 0.003
Inflammation 1.96 (−0.33 to 4.25) 0.092
Hypercholesterolemia∗∗ −0.83 (−5.31 to 3.65) 0.712
Hypertriglyceridemia −0.89 (−3.58 to 1.79) 0.508
Vitamin D deficiency 1.17 (−1.09 to 3.44) 0.304 1.83 (−0.33 to 4.00) 0.096
Anemia 0.17 (−2.26 to 2.59) 0.892
∗Hypoxia defined as a reduction of SpO2 by 10%. ∗∗Excluded from multivariable analysis due to low incidence (<10).
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mild to no SAS (Figure 2). Multivariable regression analysis
revealed that MMSE decreased with age (β = −0.25, CI, −0.45
to −0.05; p = 0.014) and in patients with diabetes (β = −4.91, CI,
−8.10 to −1.72; p = 0.01.
The median MDRS score was 120.5 (IQR, 109.3–132.0;
range, 60–143) (Table 3). Univariable regression revealed the
MDRS to be associated with SAS, OSAS, AHI, diabetes, and
hypertriglyceridemia (Table 5). The MDRS score was lower for
patients with moderate to severe SAS compared to patients with
mild to no SAS (Figure 2; p = 0.009). Multivariable regression
analysis revealed that MDRS decreased with age (β = −0.81, CI,
−1.54 to −0.08; p = 0.031), in patients with OSAS (β = −10.03,
CI, −18.26 to −1.80; p = 0.018), and in patients with diabetes
(β = −16.10, CI, −27.8 to −4.36; p = 0.008).
Twenty patients were unable to perform the Stroop test. For
the remaining patients, the median Stroop Colors delay was 19 s
(IQR, 15–29; range, 6–70) and the median number of mistakes
was 0 (IQR, 0–0; range, 0–6) (Table 3). The Stroop Words delay
was 34 s (IQR, 25–50; range, 14–147) and the median number of
mistakes was 0 (IQR, 0–1; range, 0–9). The Stroop Interference
delay was 53 s (IQR, 38–76; range, 15–116) and the median
number of mistakes was 4 (IQR, 1–13; range, 0–24). Univariable
regressions revealed the Stroop Colors delay to be associated
with age, AHI, severe SAS, and anemia (Table 6), the Stroop
FIGURE 2 | Effects of sleep apnea on cognitive scores.
Words delay to be associated with AHI (Table 7), and the Stroop
Interference delay to be associated with SAS, CSAS, AHI and
diabetes (Table 8). All three delays were increased in patients with
moderate to severe SAS compared to patients with mild to no
SAS (Figure 3, Color, p = 0.022, Word, p = 0.031, Interference,
p = 0.031). Multivariable regressions revealed that Stroop Color
delay increased with age (β = 0.64, CI, 0.09–1.19; p = 0.024)
and AHI (β = 0.17, CI, 0.02–0.32; p = 0.030), that Stroop Words
delay increased with AHI (β = 0.31, CI, 0.00–0.62; p = 0.047) and
that Stroop Interference delay increased in patients with CSAS
(β = 24.45, CI, 15.21–50.55; p = 0.0024) and in patients with
diabetes (β = 32.88, CI, 15.21–50.55; p = 0.001).
DISCUSSION
The prevalence of SAS in elderly patients admitted to our geriatric
unit was 63% (OSAS in 41% and CSAS in 22%), which is
considerably higher than that reported in the general population,
between 24 and 40% (Peppard et al., 2013; Heinzer et al.,
2015). Our results demonstrated the preeminence of SAS among
factors associated with cognitive deficit thus confirming previous
observations from the literature (Olaithe and Bucks, 2013; Aoki
et al., 2014; Arli et al., 2015; Osorio et al., 2015). It is worth noting
that the prevalence of SAS in our cohort remains higher than
recent estimates for the elderly population (25% for men and
42% for women) (Heinzer et al., 2015), which could be due to
our great proportion of patients with cognitive deficit (Moran
et al., 2005; Emamian et al., 2016). Interestingly, this finding is
in agreement with recent observations from German geriatric
wards (Gronewold et al., 2019). This study is nevertheless the
first to investigate comorbidities associating with SAS while
differentiating OSAS and CSAS in this particular population.
The patients in this cohort presented various levels of
cognitive deficit, although all were diagnosed with disorders
ranging from MCI to AD or vascular dementia. Interestingly,
in this diverse cohort, OSAS was identified as an independent
predictor of poor MDRS scores but was not associated with
MMSE scores. While both tests are used to detect cognitive
impairment in the elderly, there are indications that they may
not evaluate the same cognitive domains (Freidl et al., 1996),
or that the MDRS may be more specific and sensitive (Kaszas
et al., 2012; Holden et al., 2016). Furthermore, the ability of
the MMSE to efficiently screen for cognitive impairment in
the elderly has recently been put into question (Gagnon et al.,
2018). It is important to note that the fact that CSAS did not
affect MDRS scores in our study could be due to its lower
incidence in our cohort and is no proof of lack of effect. Our
results also revealed that AHI associates with impaired attention,
indicated by the increased delay in the Stroop Colors and
Words tests, and that CSAS and perhaps OSAS associate with
impaired executive function, indicated by the increased delay in
the Stroop Interference test. This is in line with the literature
reporting that SAS affects vigilance and the attentional domain
(Beebe et al., 2003) and executive function (Beebe et al., 2003;
Olaithe and Bucks, 2013). In 2012, Bucks et al. (2013) suggested
that OSAS may affect vigilance through sleep fragmentation
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TABLE 5 | Uni- and Multi-variable regression to identify factors associated with the Mattis Dementia Rating Scale (MDRS).
Univariable Multivariable (n = 66) Backward selection
Regression coefficient 95% C.I. (range) p-Value Regression coefficient 95% C.I. (range) p-Value
Age −0.74 (−1.52 to 0.04) 0.062 −0.81 (−1.54 to −0.08) 0.031
BMI (kg/m2) 0.14 (−0.77 to 1.06) 0.755
Female Gender −9.24 (−19.09 to 0.61) 0.066
SAS −8.78 (−17.50 to −0.05) 0.049
OSAS −9.94 (−18.72 to −1.17) 0.027 −10.03 (−18.26 to −1.80) 0.018
CSAS 2.74 (−7.35 to 12.84) 0.589
Apnea-hypopnea index (AHI) −0.23 (−0.44 to −0.01) 0.039
Sleep apnea severity
None REF
Mild 5.50 (−6.84 to 17.84) 0.377
Moderate −4.17 (−20.61 to 12.27) 0.614
Severe −9.36 (−20.06 to 1.33) 0.085
Blood Oxygen Saturation (SpO2,%) 0.83 (−1.25 to 2.90) 0.430
Sleep time with hypoxia∗ (%) 0.03 (−0.29 to 0.35) 0.865
Number of events per Night 0.01 (−0.03 to 0.04) 0.745
Diabetes −13.42 (−25.87 to −0.97) 0.035 −16.10 (−27.8 to −4.36) 0.008
Inflammation 6.35 (−2.63 to 15.33) 0.163
Hypercholesterolemia∗∗ −10.83 (−27.46 to 5.79) 0.198
Hypertriglyceridemia −9.99 (−19.91 to −0.07) 0.048
Vitamin D deficiency 0.07 (−9.39 to 8.35) 0.907
Anemia −4.93 (−14.35 to 4.49) 0.300 −4.47 (−13.13 to 4.19) 0.306
∗Hypoxia defined as a reduction of SpO2 by 10%. ∗∗Excluded from multivariable analysis due to insufficient number of observations (<10).
TABLE 6 | Uni- and Multi-variable regression to identify factors associated with the Stroop Colors Test (delay, s).
Univariable Multivariable (n = 60) Backward selection
Regression coefficient 95% C.I. (range) p-Value Regression coefficient 95% C.I. (range) p-Value
Age 0.79 (0.21–1.36) 0.008 0.64 (0.09–1.19) 0.024
BMI (kg/m2) 0.08 (−0.67–0.83) 0.829
Female gender 4.01 (−3.18–11.20) 0.269
SAS 4.24 (−2.35–10.83) 0.203
OSAS 1.27 (−5.33–7.87) 0.702
CSAS 1.55 (−6.18–9.28) 0.689
Apnea-hypopnea index (AHI) 0.24 (0.08–0.40) 0.003 0.17 (0.02–0.32) 0.030
Sleep apnea severity
None REF
Mild 4.31 (−8.62–17.25) 0.507
Moderate 3.21 (−6.17–12.60) 0.496
Severe 8.38 (0.20–16.56) 0.045
Blood oxygen saturation (SpO2,%) −0.47 (−2.05–1.10) 0.552
Sleep time with hypoxia∗ (%) −0.03 (−0.26–0.21) 0.831
Number of events per night 0.02 (−0.00–0.05) 0.063
Diabetes 6.88 (−2.59–16.34) 0.151 7.91 (−0.47–16.29) 0.064
Inflammation −1.53 (−8.20–5.14) 0.648
Hypercholesterolemia∗∗ −5.46 (−18.68–7.75) 0.411
Hypertriglyceridemia −0.01 (−8.09–8.07) 0.998
Vitamin D deficiency −5.07 (−11.48–1.35) 0.119
Anemia 6.93 (0.22–13.63) 0.043 5.98 (−0.07–12.04) 0.053
∗Hypoxia defined as a reduction of SpO2 by 10%. ∗∗Excluded from multivariable analysis due to low incidence (<10).
Frontiers in Aging Neuroscience | www.frontiersin.org 6 January 2020 | Volume 11 | Article 361
fnagi-11-00361 December 30, 2019 Time: 16:58 # 7
Attier-Zmudka et al. Sleep Apnea and Cognition in Elderly Patients
TABLE 7 | Uni- and Multi-variable regression to identify factors associated with the Stroop Words Test (delay, s).
Univariable Multivariable (n = 56) Backward selection
Regression coefficient 95% C.I. (range) p-Value Regression coefficient 95% C.I. (range) p-value
Age 1.06 (−0.13–2.25) 0.081
BMI (kg/m2) 0.70 (−0.70–2.11) 0.321
Female Gender 2.33 (−11.68–16.33) 0.741
SAS 8.59 (−4.16–21.35) 0.182
OSAS 7.23 (−5.36–19.82) 0.254
CSAS −2.35 (−17.34–12.64) 0.754
Apnea-hypopnea index (AHI) 0.31 (0.00–0.62) 0.047 0.31 (0.00–0.62) 0.047
Sleep apnea severity
None REF
Mild 15.59 (−8.58–39.76) 0.201
Moderate (−13.97–22.54) 0.640
Severe 14.59 (−0.90–30.07) 0.064
Blood oxygen saturation (SpO2,%) −1.17 (−4.14–1.80) 0.433
Sleep time with hypoxia∗ (%) −0.19 (−0.64–0.26) 0.393
Number of events per Night 0.04 (−0.01–0.09) 0.092
Diabetes 3.51 (−16.95–23.97) 0.732
Inflammation −2.20 (−15.06–10.66) 0.733
Hypercholesterolemia∗∗ 9.81 (−14.91–34.53) 0.429
Hypertriglyceridemia 0.32 (−15.34–15.99) 0.967
Vitamin D deficiency −12.08 (−24.33–0.16) 0.053
Anemia 0.05 (−13.33–13.43) 0.994
∗Hypoxia defined as a reduction of SpO2 by 10%. ∗∗Excluded from multivariable analysis due to low incidence (<10).
TABLE 8 | Uni- and Multi-variable regression to identify factors associated with the Stroop Interference Test (delay, s).
Univariable Multivariable (n = 50) Backward selection
Regression coefficient 95% C.I. (range) p-Value Regression coefficient 95% C.I. (range) p-value
Age 1.29 (−0.05–2.63) 0.059 1.13 (−0.05–2.30) 0.061
BMI (kg/m2) 0.12 (−1.41–1.66) 0.872
Female Gender 5.74 (−9.76–21.24) 0.460
SAS 16.93 (3.21–30.66) 0.017
OSAS 1.98 (−12.05–16.01) 0.778 13.57 (−0.14–27.28) 0.052
CSAS 17.18 (2.02–32.33) 0.027 24.45 (8.42–40.49) 0.004
Apnea-hypopnea index (AHI) 0.45 (−0.11–0.78) 0.011
Sleep apnea severity
None REF
Mild −6.02 (−26.26–14.23) 0.553
Moderate 7.65 (−20.32–35.62) 0.585
Severe 14.15 (−3.65–31.95) 0.116
Blood Oxygen Saturation (SpO2,%) −0.33 (−3.58–2.93) 0.840
Sleep Time with hypoxia∗ (%) 0.03 (−0.44–0.51) 0.890
Number of events per Night 0.04 (−0.02–0.09) 0.189
Diabetes 28.53 (−8.65–48.41) 0.006 32.88 (15.21–50.55) 0.001
Inflammation −0.52 (−14.80–13.77) 0.942
Hypercholesterolemia∗∗ −12.64 (−42.31–17.02) 0.395
Hypertriglyceridemia 13.97 (−2.22–30.16) 0.089
Vitamin D deficiency −6.85 (−20.71–7.02) 0.326
Anemia 8.65 (−5.91–23.21) 0.238
∗Hypoxia defined as a reduction of SpO2 by 10%. ∗∗Excluded from multivariable analysis due to low incidence (<10).
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FIGURE 3 | Effects of sleep apnea on Stroop tests.
and executive function through hypoxia. In this study, we
measured hypoxia and sleep apnea severity (AHI) separately
but were not able to verify this hypothesis. It is unclear why,
unlike previous literature, AHI rather than oxygen desaturation
was associated with cognitive deficit in our cohort, though it
could be due to the different manifestations in SAS in the
elderly population and in the general population (Al Lawati
et al., 2009; Heinzer et al., 2015). The relationship between
intermittent hypoxia and cognition remain complex, however,
and animal studies have suggested that intermittent hypoxia may
not directly impair brain structure (Jorba et al., 2017), but may
play a role in the etiology of Alzheimer’s Disease (Shiota et al.,
2013; Menal et al., 2018; Macheda et al., 2019). Nevertheless,
fragmented sleep and excessive daytime sleepiness have been
shown to modify the relationship between AHI and several
co-morbidities (Nena et al., 2012; Ren et al., 2016) and could
contribute to cognitive decline in SAS patients (Zhou et al., 2016).
Unfortunately, daytime sleepiness was not evaluated in this study,
and could therefore not be included in the multivariable model.
We found no association between the number of events per
night and cognitive outcomes, though this variable may have
underestimated sleep fragmentation, as it did not take snoring
into account. The interaction between AHI, sleep fragmentation,
daytime sleepiness, and cognitive decline in the elderly remains
therefore a question for further search.
We decided to use vascular risk factors known to associate
with SAS or AD to adjust the regression models for our cognitive
tests. Interestingly, only diabetes independently associated with
reduced MMSE and MDRS scores, as well as increased Stroop
delay. Taken together, OSAS and diabetes are associated with
a reduction of 26 points in the MDRS. Interestingly, severe
sleep apnea was shown to be associated with diabetes in the
general population (Heinzer et al., 2015). This preeminence of
diabetes among risk factors for cognitive deficit has been recently
demonstrated (Musen et al., 2018) and our results indicate
that sleep apnea should be investigated among the other risk
factors for the cognitive deficit of the elderly. Indeed, sleep
apnea treatment with continuous positive air pressure has shown
success in slowing down cognitive decline in the elderly (Kushida
et al., 2012; Troussiere et al., 2014; Osorio et al., 2015), so that
sleep apnea could be considered a modifiable risk factor for
cognitive decline in the elderly (Ancoli-Israel et al., 2008).
This study is among the first to combine a comprehensive
measure of sleep apnea, including the AHI, sleep hypoxia
and events per night, with a multivariable regression analysis
including known vascular risk factors to determine associations
with cognitive deficit in cohort of elderly patients suffering
from diffuse cognitive impairment. Moreover, the cohort was
controlled for depression and anxiety. The fact that sleep apnea
was selected among other well-established risk factors is a
powerful demonstration of its association with cognitive deficit
in these patients and suggests that sleep apnea ought to be
screened for and treated in priority when possible. Further,
our distinction of patients suffering primarily from OSAS or
CSAS offers novel insight into the effects of these different, yet
oftentimes overlapping disorders.
However, this study has several limitations. First, the age
of the patients and their cognitive impairment caused a large
number of failures of the neurocognitive assessment, especially
for the Stroop test. This has weakened our regression analyses and
increased the chance of underestimating associations. Second,
the fact that patients unable to complete the neurocognitive
tests were excluded from the study has created a potential bias,
since these patients were likely to exhibit more severe cognitive
symptoms. Third, no additional measure of dementia was used
to validate MDRS results and assess dementia severity. Fourth,
the prevalence of women in our cohort represents the population
admitted to our institution, and our results may not be applicable
for younger sleep apnea patients, which are predominantly men.
Finally, our list of competing risk factors was incomplete, as we
were unable to correctly or systematically assess the patients’
smoking habits, alcohol consumption, physical inactivity, or
daytime sleepiness.
Frontiers in Aging Neuroscience | www.frontiersin.org 8 January 2020 | Volume 11 | Article 361
fnagi-11-00361 December 30, 2019 Time: 16:58 # 9
Attier-Zmudka et al. Sleep Apnea and Cognition in Elderly Patients
CONCLUSION
This study reveals the high prevalence of sleep apnea in
elderly patients with cognitive impairment, and demonstrates
the independent association between sleep apnea and cognitive
deficit. OSAS was associated with a reduction of the MDRS score,
while CSAS was associated with an increased Stroop Interference
delay. Our data suggest that elderly patients with cognitive deficit
should be screened for sleep apnea and encouraged to follow
treatments, if necessary, to prevent cognitive decline.
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